Eris Lifesciences Limited (ERIS.BO)
INR 1321.05
(3.6%)
INR 1321.05
(3.6%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.89 Billion INR | 43.82% |
| 2022 | 1.31 Billion INR | 11.47% |
| 2021 | 1.17 Billion INR | 24.82% |
| 2020 | 944.66 Million INR | 35.97% |
| 2019 | 694.75 Million INR | -15.94% |
| 2018 | 826.53 Million INR | 26.29% |
| 2017 | 654.48 Million INR | 17.25% |
| 2016 | 558.19 Million INR | 17.22% |
| 2015 | 476.21 Million INR | -17.33% |
| 2014 | 576.05 Million INR | 28.55% |
| 2013 | 448.11 Million INR | 3.73% |
| 2012 | 431.98 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 2.56 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 1.89 Billion INR | 43.82% |
| 2023 Q4 | 1.89 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 1.39 Billion INR | 0.0% |
| 2022 FY | 1.31 Billion INR | 11.47% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 1.08 Billion INR | 0.0% |
| 2022 Q4 | 1.31 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 1.17 Billion INR | 0.0% |
| 2021 FY | 1.17 Billion INR | 24.82% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 1.03 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 902.67 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 944.66 Million INR | 35.97% |
| 2020 Q4 | 944.66 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 694.75 Million INR | 0.0% |
| 2019 FY | 694.75 Million INR | -15.94% |
| 2019 Q2 | 720.91 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 826.53 Million INR | 26.29% |
| 2018 Q4 | 826.53 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 582.64 Million INR | 0.0% |
| 2017 FY | 654.48 Million INR | 17.25% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q4 | 654.48 Million INR | 0.0% |
| 2017 Q2 | 357.55 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2016 Q2 | 507.46 Million INR | 0.0% |
| 2016 Q4 | 558.19 Million INR | 0.0% |
| 2016 Q1 | - INR | 0.0% |
| 2016 FY | 558.19 Million INR | 17.22% |
| 2015 FY | 476.21 Million INR | -17.33% |
| 2014 FY | 576.05 Million INR | 28.55% |
| 2013 FY | 448.11 Million INR | 3.73% |
| 2012 FY | 431.98 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 88.498% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 98.073% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 71.642% |
| Granules India Limited | 13 Billion INR | 85.465% |
| Indoco Remedies Limited | 3.53 Billion INR | 46.459% |
| Achyut Healthcare Limited | 568 Thousand INR | -332702.817% |
| Ajanta Pharma Limited | 8.28 Billion INR | 77.18% |
| Alkem Laboratories Limited | 26.61 Billion INR | 92.897% |
| Alpa Laboratories Limited | 136.65 Million INR | -1283.299% |
| Brooks Laboratories Limited | 96.1 Million INR | -1866.871% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 17.048% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -31.237% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -59.592% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 97.026% |
| FDC Limited | 3.88 Billion INR | 51.392% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 92.478% |
| Gufic Biosciences Limited | 2 Billion INR | 5.711% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -1707.587% |
| Ipca Laboratories Limited | 24.71 Billion INR | 92.351% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -1160.465% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -1829.607% |
| Lasa Supergenerics Limited | 190.43 Million INR | -892.638% |
| Laurus Labs Limited | 18.45 Billion INR | 89.757% |
| Lupin Limited | 49.53 Billion INR | 96.184% |
| Mankind Pharma Limited | 15.53 Billion INR | 87.832% |
| Medicamen Biotech Limited | 593.75 Million INR | -218.369% |
| Medico Remedies Limited | 163.37 Million INR | -1057.065% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | 73.015% |
| Piramal Pharma Limited | 21.75 Billion INR | 91.312% |
| RPG Life Sciences Limited | 1.01 Billion INR | -87.16% |
| Sigachi Industries Limited | 707.2 Million INR | -167.294% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 98.084% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 18.237% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -796.672% |
| Unichem Laboratories Limited | 7.04 Billion INR | 73.175% |
| Wanbury Limited | 360.23 Million INR | -424.751% |
| Windlas Biotech Limited | 621.89 Million INR | -203.964% |
| ZIM Laboratories Limited | 812.62 Million INR | -132.618% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 94.508% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | 94.063% |
| Hester Biosciences Limited | 755.81 Million INR | -150.105% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -73.249% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -553.984% |
| Bal Pharma Limited | 878.11 Million INR | -115.27% |
| Strides Pharma Science Limited | 11.26 Billion INR | 83.216% |
| Venus Remedies Limited | 1.21 Billion INR | -55.339% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 70.595% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 73.344% |
| Shilpa Medicare Limited | 3.44 Billion INR | 45.197% |
| Aarti Drugs Limited | 4.85 Billion INR | 61.096% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 55.505% |
| Suven Life Sciences Limited | 7.08 Million INR | -26580.593% |
| Ind-Swift Limited | 640.91 Million INR | -194.941% |
| Valiant Laboratories Limited | 100.15 Million INR | -1787.413% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 62.382% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 47.447% |
| Themis Medicare Limited | 705.74 Million INR | -167.848% |
| Hikal Limited | 3.03 Billion INR | 37.761% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 91.705% |
| Sequent Scientific Limited | 3.46 Billion INR | 45.403% |
| Novartis India Limited | 448.6 Million INR | -321.382% |
| Wockhardt Limited | 6.4 Billion INR | 70.464% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 85.342% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -7313.892% |
| Neuland Laboratories Limited | 3.5 Billion INR | 46.056% |
| Morepen Laboratories Limited | 2.48 Billion INR | 23.96% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -4640.02% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -52.889% |